| Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a “real-world” population with atrial fibrillation receiving anticoagulant therapy V Roldán, F Marín, H Fernández, S Manzano-Fernandez, P Gallego, ... Chest 143 (1), 179-184, 2013 | 275 | 2013 |
| The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial … V Roldán, F Marín, S Manzano-Fernández, P Gallego, JA Vílchez, ... Journal of the American College of Cardiology 62 (23), 2199-2204, 2013 | 242 | 2013 |
| Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation P Gallego, V Roldan, F Marín, M Romera, M Valdés, V Vicente, GYH Lip Thrombosis and haemostasis 110 (12), 1189-1198, 2013 | 216 | 2013 |
| Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation P Gallego, V Roldán, JM Torregrosa, J Gálvez, M Valdés, V Vicente, ... Circulation: Arrhythmia and Electrophysiology 5 (2), 312-318, 2012 | 186 | 2012 |
| SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation P Gallego, V Roldán, F Marin, J Gálvez, M Valdés, V Vicente, GYH Lip The American journal of medicine 127 (11), 1083-1088, 2014 | 166 | 2014 |
| Renal impairment in a “real-life” cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding) V Roldán, F Marín, H Fernández, S Manzano-Fernández, P Gallego, ... The American journal of cardiology 111 (8), 1159-1164, 2013 | 145 | 2013 |
| Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? V Roldán, F Marín, S Manzano-Fernández, H Fernández, P Gallego, ... Thrombosis and haemostasis 109 (05), 956-960, 2013 | 124 | 2013 |
| Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation P Gallego, S Apostolakis, GYH Lip Circulation 126 (13), 1573-1576, 2012 | 87 | 2012 |
| Safety of new oral anticoagulant drugs: a perspective JA Vílchez, P Gallego, GYH Lip Therapeutic advances in drug safety 5 (1), 8-20, 2014 | 79 | 2014 |
| Circulating microparticles: challenges and perspectives of flow cytometric assessment E Shantsila, S Montoro-García, P Gallego, GYH Lip Thrombosis and haemostasis 111 (06), 1009-1014, 2014 | 72 | 2014 |
| Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation E Jover, V Roldan, P Gallego, D Hernandez-Romero, M Valdes, V Vicente, ... Revista Española de Cardiología (English Edition) 65 (7), 627-633, 2012 | 56 | 2012 |
| Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation S Manzano-Fernandez, JM Andreu-Cayuelas, F Marin, E Orenes-Pinero, ... Revista Española de Cardiología (English Edition) 68 (6), 497-504, 2015 | 53 | 2015 |
| Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation D Luque Paz, R Jouanneau-Courville, J Riou, JC Ianotto, F Boyer, ... Blood Advances 4 (19), 4887-4897, 2020 | 51 | 2020 |
| Blinatumomab+ ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults MA Couturier, X Thomas, E Raffoux, F Huguet, C Berthon, C Simand, ... Leukemia & lymphoma 62 (3), 620-629, 2021 | 49 | 2021 |
| Novel oral anticoagulants in cardiovascular disease P Gallego, V Roldán, GYH Lip Journal of Cardiovascular Pharmacology and Therapeutics 19 (1), 34-44, 2014 | 41 | 2014 |
| Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation P Gallego, V Roldán, F Marín, E Jover, S Manzano‐Fernández, M Valdés, ... European journal of clinical investigation 42 (12), 1302-1308, 2012 | 35 | 2012 |
| Valor predictivo de la escala CHA2DS2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante E Jover, V Roldán, P Gallego, D Hernández-Romero, M Valdés, V Vicente, ... Revista Española de Cardiología 65 (7), 627-633, 2012 | 26 | 2012 |
| Apixaban compared with warfarin for stroke prevention in atrial fibrillation: implications of time in therapeutic range P Gallego, JA Vilchez, DA Lane Circulation 127 (22), 2163-2165, 2013 | 25 | 2013 |
| Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: results of a retrospective study E Cayssials, J Torregrosa‐Diaz, P Gallego‐Hernanz, F Tartarin, ... Cancer 126 (15), 3438-3447, 2020 | 24 | 2020 |
| Observational study of vaccination in cancer patients: How can vaccine coverage be improved? A Monier, M Puyade, MPG Hernanz, P Bouchaert, X Leleu, JM Tourani, ... Medecine Et Maladies Infectieuses 50 (3), 263-268, 2020 | 24 | 2020 |
